Langford, Carol A <br/><br/>
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  04 2017 
 - 846-853 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.40037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept--therapeutic use<br/>Adolescent<br/>Adult<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Takayasu Arteritis--drug therapy<br/>Young Adult